About
Technology
Issues
FAQ
Links
Official Page
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.